Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer

Comprehensive characterization of the genomic landscape of epidermal growth factor receptor (EGFR)-mutated lung cancers have identified patterns of secondary mutations beyond the primary oncogenic EGFR mutation. These include concurrent pathogenic alterations affecting p53 (60–65%), RTKs (5–10%), PI...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Thorac Dis
Prif Awduron: Gini, Beatrice, Thomas, Nicholas, Blakely, Collin M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2020
Pynciau:
Review Article on Mechanisms of Resistance to EGFR-targeted Therapy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330397/
https://ncbi.nlm.nih.gov/pubmed/32642201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.03.78
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg